D-0167-2020 Class III Terminated
FDA drug recall D-0167-2020 was initiated by Arbor Pharmaceuticals Inc. on Sep 27, 2019 and is designated Class III. Reason for recall: Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection… The recall status is terminated (terminated Feb 2, 2021). Affected quantity: 67934 units.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 6, 2019
- Initiation Date
- Sep 27, 2019
- Termination Date
- Feb 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 67934 units
Product description
Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01
Reason for recall
Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials
Distribution pattern
Nationwide in the US
Code information
lot# 23803.002B, Exp 07/2020; 23803.005A, Exp 01/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0167-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026